Claritas Pharmaceuticals Financial Health

How is Claritas Pharmaceuticals's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: CLAS's short term assets ($11.0M) exceed its short term liabilities ($7.7M).

Long Term Liabilities: CLAS's short term assets ($11.0M) exceed its long term liabilities ($10.0K).


Debt to Equity History and Analysis

Debt Level: CLAS's net debt to equity ratio (16.3%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if CLAS's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: CLAS's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: CLAS's interest payments on its debt are not well covered by EBIT (0.2x coverage).


Balance Sheet


Discover healthy companies